Diabetes Drug, Pioglitazone, May Prevent Secondary Strokes (CME/CE)

(MedPage Today) -- Post hoc IRIS analysis points to benefit, although adverse effects still widely seen as off-putting
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news